Healthcare · Pharmaceuticals & Biotechnology
QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.
Source: Wikipedia
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #43 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 25 Mar 2022 | Pronomz Ventures LLP | Promoter | Buy | 0 | ₹0 |
| 24 Mar 2022 | Pronomz Ventures LLP | Promoter | Buy | 0 | ₹0 |
| 17 Mar 2022 | AGRAGANYA PRIVATE TRUST | Promoter group | Buy | 0 | ₹0 |
| 15 Mar 2022 | Pronomz Ventures LLP | Promoter | Buy | 0 | ₹0 |
| 4 Mar 2022 | Pronomz Ventures LLP | Promoter | Buy | 0 | ₹0 |
| 28 Feb 2022 | Arun Kumar | Promoter | Buy | 0 | ₹0 |
| 28 Feb 2022 | Karuna Business Solutions LLP | Promoter group | Buy | 0 | ₹0 |
| 28 Sep 2021 | Amit Kumar Himmatsinghka | Employee / designated person | Sell | 0 | ₹0 |
| 24 Sep 2021 | SANDEEP BAID | Employee / designated person | Sell | 0 | ₹0 |
| 22 Sep 2021 | ARAVINDA. R | Employee / designated person | Sell | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 28 Aug 2026 | SBI LIFE INSURANCE CO.LTD. | Bulk | Sell | 1,000,000 | 990.0000 | NSE |
| 28 Aug 2026 | ARUN KUMAR PILLAI | Bulk | Buy | 1,000,000 | 990.0000 | NSE |
| 28 Aug 2026 | SBI LIFE INSURANCE CO.LTD. | Block | Sell | 1,000,000 | 990.0000 | NSE |
| 28 Aug 2026 | ARUN KUMAR PILLAI | Block | Buy | 1,000,000 | 990.0000 | NSE |
| 31 Oct 2025 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 578,738 | 938.6900 | NSE |
| 31 Oct 2025 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Buy | 578,738 | 937.2200 | NSE |
| 22 Jan 2025 | AUTHUM INVESTMENT & INFRASTRUCTURE LIMITED | Bulk | Buy | 518,350 | 558.8800 | NSE |
| 9 Feb 2024 | BAJAJ FINANCE LIMITED | Block | Sell | 240,800 | 713.0000 | BSE |
| 9 Feb 2024 | AMANSA HOLDING PRIVATE LTD. | Block | Buy | 240,800 | 713.0000 | BSE |
| 9 Feb 2024 | SHASUN LEASING & FINANCE PVT LTD | Block | Sell | 335,672 | 713.0000 | BSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 31 Jul 2026 | Dividend - Rs 5 Per Share | 5.0000 | 31 Jul 2026 |
| 22 Jul 2025 | Dividend - Rs 4 Per Share | 4.0000 | 22 Jul 2025 |
| 9 Sep 2024 | Dividend - Rs 2.50 Per Share | 2.5000 | 9 Sep 2024 |
| 4 Aug 2023 | Dividend - Rs 1.50 Per Share | 1.5000 | 4 Aug 2023 |
| 5 Aug 2021 | Dividend - Rs 2.50 Per Share | 2.5000 | 6 Aug 2021 |
| 24 Jul 2020 | Annual General Meeting/Dividend - Rs 2 Per Share | 2.0000 | 27 Jul 2020 |
| 22 Aug 2019 | Interim Dividend - Rs 12 Per Share | 12.0000 | 23 Aug 2019 |
| 19 Jul 2019 | Annual General Meeting/Dividend - Rs 3 Per Share | 3.0000 | — |
| 12 Sep 2018 | Annual General Meeting/Dividend Rs 2 Per Share | 2.0000 | — |
| 7 Sep 2017 | Annual General Meeting/Dividend - Rs 4.50 Per Share | 4.5000 | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| — | NAME_CHANGE | Name changed from Stride Arcolab Ltd. to Strides Shasun Limited |
| — | NAME_CHANGE | Name changed from Strides Shasun Limited to STRIDES PHARMA SCIENCE LIMITED |
| 6 Dec 2024 | MERGER | Demerger |
| 6 Apr 2018 | SCHEME_OF_ARRANGEMENT | Scheme Of Arrangement |
| 16 Apr 2009 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 31 Jul 2026 | Financial Results | Yes |
| 18 May 2026 | Financial Results/Dividend | Yes |
| 30 Jan 2026 | Financial Results | Yes |
| 31 Oct 2025 | Financial Results | Yes |
| 29 Jul 2025 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Board of directors and corporate information →
Single-stock futures available for this stock -- OI buildup, PCR, Max Pain and Greeks are all on the full F&O page.
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
